SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Conditions
Pancreatic Adenocarcinoma Metastatic · BRCA1 Mutation · BRCA2 Mutation · Pancreatic Acinar Cell Carcinoma · Pancreatic Ductal Adenocarcinoma · Pancreatic Cancer · Metastatic Pancreatic Cancer · Metastatic Pancreatic Ductal Adenocarcinoma · Breast Cancer Metastatic · Breast Cancer Stage IV · Pancreatic Cancer Stage IV · HER2-negative Breast Cancer · HER2 Negative Breast Carcinoma · Adenocarcinoma of the Breast · PALB2 Gene Mutation · Pancreas Cancer, Metastatic · Pancreas Cancer, Recurrent · Pancreas Cancer · Stage IV Pancreatic Cancer · Stage 4 Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Massachusetts General Hospital, Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Kenneth H Yu, M.D.)Contact: Principal Investigator (Kenneth H Yu, M.D.)
Study leads
Arnold Glazier, M.D.
Study Director
General Oncology, Inc.